
CEIBA INVESTMENTS LIMITED
("CEIBA" or the "Company")
(TICKER CBA, ISIN: GG00BFMDJH11)
Legal Entity Identifier: 213800XGY151JV5B1E88
AMENDMENT OF BOND INSTRUMENT (22 MARCH 2021)
In CEIBA's RNS Announcement of 13 January 2025 the Company announced proposals to the holders (the "Bondholders") of the €25,000,000 10% senior unsecured convertible bonds due 2026 (the "Bonds") issued by the Company in order to approve, by way of extraordinary resolutions (the "Extraordinary Resolutions"), the entering into of an amendment agreement (the "Amendment Agreement") to modify the original bond instrument dated 22 March 2021 constituting the Bonds. The text of the Amendment Agreement was previously circulated to Bondholders and also appears on the website of the Company. In order to be passed successfully, the Extraordinary Resolutions required Bondholders together holding at least 60% of the principal amount of the Bonds to vote in their favour.
The Board is very pleased to announce that Bondholders together holding over 85% of the principal amount of the Bonds have voted in favour of the Extraordinary Resolutions and as a result, as of 24 January 2025 (the date upon which the 60% threshold was surpassed), the Amendment Agreement was executed and came into effect. The Bond Instrument and the Amendment Agreement are available on the website of the Company (www.ceibainvest.com).
The principal amendments made to the terms of the Bonds modify the payment schedule from a single €25 million bullet payment due on 31 March 2026 to five equal annual instalments of €5 million, to be made starting in June 2025.
The Bonds are listed on The International Stock Exchange ("TISE") and a copy of the Amendment Agreement shall be provided to TISE in order to reflect the changes to the Original Bond Instrument and the new maturity date of the Bonds being 31 March 2029.
For further information, please contact:
Sebastiaan Berger
| Via NSM Funds Limited |
Singer Capital Markets James Maxwell / Patrick Weaver (Corporate Finance) James Waterlow (Sales)
| Tel: +44 (0)20 7496 3000 |
NSM Funds Limited | Tel: +44 (0)1481 743030
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.